Evofem Biosciences
(OTC) EVFM
Evofem Biosciences Financials at a Glance
Market Cap
$1.11M
Revenue (TTM)
$20.18M
Net Income (TTM)
$391.00K
EPS (TTM)
$-0.01
P/E Ratio
-1.12
Dividend
$0.00
Beta (Volatility)
0.57 (Low)
Dividend
$0.00
Beta (Volatility)
0.57 (Low)
Price
$0.01
Volume
177,543
Open
$0.01
Price
$0.01
Volume
177,543
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.02
Dividend
$0.00
Beta (Volatility)
0.57 (Low)
Price
$0.01
Volume
177,543
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.02
EVFM News
EVFM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Evofem Biosciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
29
CEO
Saundra L. Pelletier
Website
www.evofem.comHeadquarters
San Diego, CA 92130, US
EVFM Financials
Key Financial Metrics (TTM)
Gross Margin
75%
Operating Margin
7%
Net Income Margin
2%
Return on Equity
0%
Return on Capital
-2%
Return on Assets
2%
Earnings Yield
-89.29%
Dividend Yield
0.00%
Payout Ratio
29.92%
Stock Overview
Market Cap
$1.11M
Shares Outstanding
132.53M
Volume
177.54K
Short Interest
0.00%
Avg. Volume
265.48K
Financials (TTM)
Gross Profit
$15.07M
Operating Income
$1.44M
EBITDA
$2.06M
Operating Cash Flow
$1.99M
Capital Expenditure
$5.00K
Free Cash Flow
$2.00M
Cash & ST Invst.
$578.00K
Total Debt
$65.87M
Evofem Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$9.56M
+34.6%
Gross Profit
$6.55M
+17.1%
Gross Margin
68.51%
N/A
Market Cap
$1.11M
N/A
Market Cap/Employee
$34.79K
N/A
Employees
32
N/A
Net Income
$2.79M
+191.8%
EBITDA
$3.49M
+643.5%
Quarterly Fundamentals
Net Cash
$65.29M
-44.4%
Accounts Receivable
$12.48M
+26.9%
Inventory
$1.13M
-28.4%
Long Term Debt
$54.00K
+671.4%
Short Term Debt
$65.81M
+43.2%
Return on Assets
1.93%
N/A
Return on Invested Capital
-2.23%
N/A
Free Cash Flow
$28.00K
+101.2%
Operating Cash Flow
$31.00K
+101.3%